Therapy Insight: peripheral arterial disease and diabetes—from pathogenesis to treatment guidelines
Emile R Mohler III
Correspondence Hospital of the University of Pennsylvania, 4th Floor Penn Tower Building, 3400 Spruce Street, Philadelphia, PA 19104, USA
Email emile.mohler@uphs.upenn.edu
Approximately one-third of patients with diabetes have peripheral arterial disease (PAD) and concomitant diabetes amplifies the already high risk of atherothrombotic events present in those with PAD. Here, Emile R Mohler III discusses atherothrombosis and PAD in patients with diabetes in the context of the 2006 American College of Cardiology/American Heart Association guidelines for PAD management.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Subclinical peripheral arterial disease in patients with chronic kidney disease: Prevalence and related risk factorsKidney International Original Article
Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscleGene Therapy Research Article
